Figure S1 Middle-aged mice (44 weeks old) were subjected to vehicle (control), 10 mg/kg SYR (SYR 10), 50 mg/kg SYR (SYR 50) or 30% CR treatment for 10 weeks (n = 6, group). All results are expressed as means ± SEM.
Statistical analyses were performed using one-way ANOVA followed by Dunnett's post hoc test. ** P < 0.01, ***P < 0.001 versus the untreated middle-aged control group. Experiments were repeated three times. Data are the averages of three independent experiments. Middle-aged mice were subjected to vehicle (control), 10 mg/kg SYR (SYR 10), 50 mg/kg SYR (SYR 50) or 30% CR treatment for 10 weeks (n=6, group). Young mice were used as age-mismatched controls. All data are expressed as means ± SEM. Statistical analysis were performed using one-way ANOVA followed by Dunnett's post hoc test. * P < 0.05, ** P < 0.01, *** P < 0.001 versus the untreated middle-aged control group; ns, non- 14.2 ± 2.4 30.5 ± 2.6 26.6 ± 2.9 22.9 ± 2. Middle-aged mice were subjected to vehicle (control), 10 mg/kg SYR (SYR 10), 50 mg/kg SYR (SYR 50) or 30%
CR treatment for 10 weeks (n=6, group). Young mice were used as age-mismatched controls. All data are expressed as means ± SEM. Statistical analysis were performed using one-way ANOVA followed by Dunnett's post hoc test. * P < 0.05, ** P < 0.01, *** P < 0.001 versus the untreated middle-aged control group; ns, nonsignificant. Middle-aged mice were subjected to vehicle (control), 10 mg/kg SYR (SYR 10), 50 mg/kg SYR (SYR 50) or 30% CR treatment for 10 weeks (n=6, group). Young mice were used as age-mismatched controls. Mean ± SEM. 
